Monday, November 23, 2015 12:03:46 PM
So .... why would any investor have even the slightest interest in buying ZIVO stock at the moment given the news of the last 12 months ???
As one can see below, the end of last year and start of this year looked very promising. A broad trial test of Wellmetris, and very positive Zoetis collaboration results.
Since then ....... crickets ........... nearly 11 months ...... still waiting on that "money event" .....
Little nuggets here and there .... like that LOI with algae grower in Florida to produce hundreds of pounds of the biomass .... still could happen but .....
ZIVO presently on the main page of CEOCast .... but its really a worthless view .... sez nothing
http://www.ceocast.com/
Thus far the CEOCast tour of New York hasn't produced anything thus far .... although these things typically take some time .... but if compelling enough ..... shouldn't really take much time at all .... relatively speaking.
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
09/09/15
- ZIVO Bioscience Open WellMetris Assay Development Lab at Notre Dame Innovation Center Nice and should help move things along but if you aren't moving in the first place ....... hmmmmm .....
06/17/15
- ZIVO Bioscience, Inc. Annual Shareholder Meeting and Conference Call Slated for June 23,2015 in Detroit, Michigan "funding", "funding", "funding"
05/06/15
- ZIVO Bioscience Announces Increase in Credit Facility From Primary Lender and Notice of Convertible Debt Conversion Angels increase their commitment . although if I understand correct, if the Angels had funded that whole thing immediately we would have had movement on at least 1 front already ...... AND ..... statements made by primary lender indicating an orderly conversion of debt haven't proven to have occurred. To date, doesn't look like any conversion has happened. And of course the premise for the comments made no sense to me at the time anyway. The stock doesn't need liquidity, it needs scarcity. Of course conversion is double-edged. Would be nice to reduce interest costs.
01/08/15
- ZIVO Bioscience Announces Amended Convertible Debt Structure and Continued Support From Primary Lender Angels kindly fixed the conversion rates. Removed floorless clause. Very positive indication at the time.
01/06/15
- ZIVO Bioscience Concludes Bovine Mastitis Pilot Study with Promising Results in Combatting Mycoplasma Pathogen Very positive. And with additional information provided later, we know Zoetis is/was willing to shorten the testing originally requested (due to positive results on multiple candidates) to complete the collaboration ...... for which investors are still waiting .........
12/02/14
- ZIVO Bioscience and WellMetris Subsidiary Announce Pilot Program and Pending Order for Point of Care Wellness Test ...And still we wait ..... i.e. hasn't happened ....
<<<<<<<<<<<<<<<<<<<<<<<<<
Amigo Mike
Recent ZIVO News
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/26/2024 05:36:56 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/26/2024 12:05:12 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 04/09/2024 03:49:14 PM
- Form SCHEDULE 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 03/14/2024 01:16:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:45:37 PM
- Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities • Edgar (US Regulatory) • 02/15/2024 01:54:37 PM
- ZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study • Business Wire • 02/07/2024 09:54:00 PM
- ZIVO Bioscience Announces Uplisting to OTCQB Market • Business Wire • 01/29/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 09:11:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 10:17:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:05:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 10:23:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 09:12:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/27/2023 02:29:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/22/2023 09:21:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:18:41 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 10/30/2023 05:20:31 PM
- ZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens • Business Wire • 10/30/2023 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/26/2023 12:56:59 PM
- ZIVO Bioscience Announces Reverse Stock Split • Business Wire • 10/26/2023 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 10/04/2023 09:08:51 PM
- ZIVO Bioscience to Present at the Dawson James Small Cap Growth Conference • GlobeNewswire Inc. • 10/03/2023 12:30:00 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM